Fulminant Necrotizing Fasciitis and Nonsteroidal Anti-Inflammatory Drugs
Necrotizing fasciitis is a distinct clinical entity usually caused by Steptococcus pyogenes. Although accurately defined by Wilson [1] in 1952, the disease is often unrecognized. It is potentially fatal, especially when it becomes fulminant. Even though the host factors and the infectious agent responsible for initiating and spreading necrotizing fasciitis have been identified, the pathogenesis of the disease is unclear. After examining all cases of necrotizing fasciitis occurring in the intensive medical care unit Received for publication 2 June 1986, and in revised form 9 July 1986.
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Patients
We included only those patients who had necrotizing fasciitis that fulfilled strict criteria: a soft-tissue infection involving the superficial fascia and resulting in extensive undermining of surrounding tissues. The infection was considered fulminant when the delay between the first functional and local signs and surgery did not exceed six days (table 1) .
All patients had previously been healthy, and none had a predisposing condition -previous surgery, chronic ve- " «
Discussion
Necrotizing fasciitis is a relatively rare disease that is often difficult to diagnose during the early stages, when the skin is apparently still normal. However, the outcome of this potentially fatal disease is largely influenced by early recognition and prompt therapy based upon antibiotics and surgery [2] . Stamenkovic and Lew [3] recently suggested that rapid performance of frozen-section soft-tissue biopsy early in the evolution of a suspect lesion may provide a definitive and life-saving diagnosis. In our patients, as in many others, necrotizing fasciitis was not initially suspected; therefore, no biopsy was performed, and treatments were prescribed for conditions such as arthritis or phlebitis. Necrotizing fasciitis usually requires both a specific organism and an underlying debilitating disease [4, 5] . Although group A l3-hemolytic Streptococcus has long been recognized as the agent of this infection, recent reports [6, 7] indicated that necrotizing fasciitis can be caused by a variety of bacteria. In patient 6, the agent was the gramnegative bacillus Serratia marcescens. The hypothesis [8] that production of hernolysins, fibrinolysins, and hyal-nous or arterial ulcer, or debilitating disease -that could have altered their normal defense mechanisms. Three of the five patients reported recent, minor injuries. Initially, a false diagnosis -arthritis or phlebitis -was made on the basis of pain and edema without subcutaneous abnormalities, and the usual nonsteroidal anti-inflammatory drugs were prescribed, but no antibiotics were administered, Each patient's local and general signs reached a critical point, which included serious disorders (especially shock). An obvious diagnosis of necrotizing fasciitis was established, and the patients were admitted into the intensive care unit. All patients except patient 4 (who received penicillin 36 hr before admission) became septicemic with a single organism -a Lancefield's group A l3-hemolytic Streptococcus in most cases -and had positive cultures of the same organism from blisters or areas of necrosis. Treatment in the intensive care unit included iv penicillin (15-25 X 10 6 Ll/day), fluid replacement, cardiac inotropic drugs, and surgery. Three patients died of septic shock within 15-48 hr after admission, despite excision surgery and aggressive medical treatment. Two patients survived after prolonged hospitalization and repeated surgery and grafting.
During this period, two other patients were admitted with necrotizing fasciitis: a 53-year-old diabetic man with a chronic arterial ulcer and an 82-year-old woman with a chronic venous ulcer. Neither one had previously received anti-inflammatory drugs or antibiotics. The disease had a subacute evolution in both patients (15 and 12 days, respectively, from first local signs to overt necrotizing fasciitis), and cultures of blood were negative. Both patients survived after treatment with penicillin and surgery. .,.
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'" The action of bacterial toxins, together with the effect of bacterial kinases, is further enhanced by the general reduction in host defense that occurs during the postoperative period, by preexisting systemic diseases such as diabetes and malnutrition, or by conditions requiring prolonged treatment with steroids [2, 8] . However, all five of our patients were previously healthy, and no underlying disease could be found. They were all treated with nonsteroidal anti-inflammatory drugs just after diagnosis of the disease. A marked acceleration of the evolution was then observed in all patients, although no other drug was given during the early stages. Necrotizing fasciitis is generally considered a fulminating disease, but the delay between first signs and surgical treatment is usually more than six days. In Freeman's study [7] , most patients with necrotizing fasciitis had symptoms of disease for four days to three weeks before presenting at the hospital; the most severe infections were in patients who waited 10 to 14 days before going to the hospital. Almost all the patients had an underlying disease, and none received immunodepressive drugs [7] . In Hammar's study [4] , patients with necrotizing fasciitis had been ill for four to five days before admission to the hospital, and all but two developed gangrenous ulcers that appeared at least one week after the beginning of the disease. Almost all patients presented with other diseases, but none received oral steroids or other immunodepressive drugs. In Leppard's study [9] , patients with necrotizing fasciitis were divided into two groups: In the first group, the eight patients did not receive any antibiotics before admission and the evolution was considered fulminating (but the time between presentation and diagnosis was not mentioned); in the second group, the five patients had been previously treated with antibiotics, and an interval of several weeks passed before the skin became necrotic. No patients in either group received antiinflammatory drugs. In our intensive care unit, we observed that the two non-fulminating cases of necrotizing fasciitis occurred in patients who did not receive non-steroidal anti-inflammatory drugs or antibiotics. Some cases of necrotizing fasciitis have been recently reported [10] in patients given one or several steroidal and non-steroidal antiinflammatory drugs; the delay from triggering event to overt necrotizing fasciitis and referral to hospital was from four to ten days. The limited number of patients we observed does not warrant a statistical study to affirm that non-steroidal anti-inflammatory drugs were directly responsible for a fulminating evolution in necrotizing fasciitis, but the shorter delays in our study than in previous ones is a convincing argument to establish the deleterious role of such drugs.
The mechanism can be deduced from previous studies. Activation of infection in debilitated patients treated with anti-inflammatory drugs has been reported [11] . Obser-145 vations that granulocyte-mediated functions -chemotaxis, phagocytosis, and bactericidal activity -are impaired in vitro by nonsteroidal drugs have been supported by decreased in vitro bactericidal activity and reduced activation of Staphylococcus aureus and group B Streptococcus by granulocytes incubated with phenylbutazone [12] . Inhibition of granulocyte adherence has been demonstrated to be secondary to the anti-inflammatory effect of aspirin [13] .
In a recent case report [14] , a life-threatening case of necrotizing fasciitis occurred in a 23-year-old, previously healthy woman who took six diflunisal tablets over a 24hr period after a minor injury; lymphocyte function and lymphocyte transformation were severely depressed. The authors suggested that these troubles represented an adverse reaction to the drug that contributed to the severe sepsis that developed. This patient had nearly normal levels of serum immunoglobulins, as did three of our five patients. It appears that the possible deleterious effect of nonsteroidal anti-inflammatory drugs results from deep and quick depression of cellular defense.
Our observations suggest that non-steroidal antiinflammatory drugs should not be used for apparently benign inflammatory cutaneous lesions when infection cannot be avoided. ALAIN 
